Catalog #CND10
CJC-1295 (Without DAC)
10 MG
Select Research Tier:
Batch-tested · Research-grade purity · Certificate of Analysis included
Quantity:
Line Total:
$50.00
Technical Research Description
CJC-1295 (without DAC) is a synthetic 29-amino acid analog of growth hormone-releasing hormone (GHRH). Also known as Mod GRF 1-29, it features four amino acid substitutions that increase stability and receptor binding while maintaining a shorter half-life than the DAC version.
Simplified Explanation
This modified version of a natural growth hormone-releasing hormone is designed to be more stable without the long-lasting "Drug Affinity Complex." It stimulates natural growth hormone release in pulses. Researchers often combine it with other peptides to study synergistic effects.
For Research Use Only
DISCLAIMER: This product is sold for research purposes only. Not for human consumption.
By purchasing, you confirm that you are a qualified researcher or represent a research institution, and that this product will be used solely for in-vitro research or lawful scientific study.
Customer Reviews
No reviews yet — be the first to share your experience.
From Our Research Blog
Background reading and laboratory context for CJC-1295 (Without DAC) 10 MG — sourced from our research articles.
research
CJC-1295 (Without DAC): What It Enables in GH Research
A research-first look at CJC-1295 (Without DAC): receptor pharmacology, pulse biology, assay design, and how it differs from DAC v…
Sep 1, 2026
research
Sermorelin Acetate: A GHRH Analog for GH Studies
Sermorelin acetate is a GHRH analog used to probe pituitary GH release in preclinical models. Here's how researchers design studie…
Sep 9, 2026
research
AOD-9604 in preclinical metabolism research: what we know
AOD-9604 is a GH-fragment research peptide studied for lipid handling and metabolic signaling. Here's what preclinical data sugges…
Sep 4, 2026
research
Tesamorelin: what it reveals about GH pulse biology
Tesamorelin is a GHRH analog used in growth-axis research. Here's what the literature suggests about pulsatile GH signaling and st…
Aug 26, 2026
research
Ipamorelin in GH Signaling: What the Data Suggests
Ipamorelin is a ghrelin-receptor agonist used in GH-axis research. Here's what preclinical literature suggests about signaling, se…
Aug 13, 2026
research
CJC-1295 (With DAC): designing longer GH signals
A research-focused look at CJC-1295 (With DAC), how DAC extends exposure, and where it fits among GHRH analogs and secretagogues.
Aug 8, 2026